trifluoperazine has been researched along with Acquired Immunodeficiency Syndrome in 1 studies
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, G | 1 |
Zhou, T | 1 |
Radding, W | 1 |
Saag, MS | 1 |
Mountz, JD | 1 |
McDonald, JM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Trial of Tamoxifen Combined With Amphotericin B and Fluconazole for Cryptococcal Meningitis[NCT03112031] | Phase 2 | 50 participants (Actual) | Interventional | 2017-10-10 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for trifluoperazine and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Apoptosis; Calmodulin; CD4-Positive T-Lymphocytes; DNA; Dopamine | 1998 |